We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
-1.91%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$10.4B
AUM Growth
-$1.74B
Cap. Flow
-$623M
Cap. Flow %
-6.01%
Top 10 Hldgs %
17.4%
Holding
476
New
95
Increased
124
Reduced
143
Closed
82

Top Buys

Rank Stock Value
1
ESTC icon
Elastic
ESTC
+$85.5M
2
GH icon
Guardant Health
GH
+$83.4M
3
SE icon
Sea Limited
SE
+$76.3M
4
EXLS icon
EXL Service
EXLS
+$58.8M
5
GTLB icon
GitLab
GTLB
+$52M

Top Sells

Rank Stock Value
1
CORZ icon
Core Scientific
CORZ
+$144M
2
SMTC icon
Semtech
SMTC
+$126M
3
FRPT icon
Freshpet
FRPT
+$120M
4
MOD icon
Modine Manufacturing
MOD
+$118M
5
ALAB icon
Astera Labs
ALAB
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 24.7%
2 Technology 18.1%
3 Industrials 15.29%
4 Consumer Discretionary 11.87%
5 Financials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLNO
176
DELISTED
Soleno Therapeutics
SLNO
$17.7M 0.17%
+247,737
New +$12.1M
RDDT icon
177
Reddit
RDDT
$27.1B
$17.2M 0.17%
163,862
-10,406
-6% -$1.72M
EXEL icon
178
Exelixis
EXEL
$13.3B
$17.1M 0.17%
463,949
+117,006
+34% +$4.17M
VRDN icon
179
Viridian Therapeutics
VRDN
$2.09B
$17.1M 0.17%
1,270,481
-605,395
-32% -$10.3M
ARQT icon
180
Arcutis Biotherapeutics
ARQT
$3.36B
$17.1M 0.16%
1,092,735
-4,034
-0.4% -$56.8K
PAYO icon
181
Payoneer
PAYO
$2.42B
$17.1M 0.16%
2,337,504
+414,695
+22% +$3.87M
ENVX icon
182
Enovix
ENVX
$892M
$17.1M 0.16%
2,655,557
+47,496
+2% +$423K
LGND icon
183
Ligand Pharmaceuticals
LGND
$5.76B
$17.1M 0.16%
162,170
-601
-0.4% -$68K
GDYN icon
184
Grid Dynamics Holdings
GDYN
$559M
$16.9M 0.16%
1,080,536
+205,634
+24% +$4.12M
SRRK icon
185
Scholar Rock
SRRK
$5.67B
$16.5M 0.16%
514,092
-1,913
-0.4% -$73.6K
BURL icon
186
Burlington
BURL
$23.2B
$16.4M 0.16%
68,797
-6,588
-9% -$1.71M
AVPT icon
187
AvePoint
AVPT
$2.76B
$16.2M 0.16%
1,124,918
+106,513
+10% +$1.79M
ADPT icon
188
Adaptive Biotechnologies
ADPT
$3.59B
$16M 0.15%
2,152,335
+1,306,164
+154% +$10M
LOPE icon
189
Grand Canyon Education
LOPE
$3.79B
$15.8M 0.15%
+91,293
New +$15.8M
FICO icon
190
Fair Isaac
FICO
$24.3B
$15.8M 0.15%
8,550
+427
+5% +$791K
CNTA
191
DELISTED
Centessa Pharmaceuticals
CNTA
$15.8M 0.15%
1,095,533
-502,650
-31% -$8.23M
ALNY icon
192
Alnylam Pharmaceuticals
ALNY
$27.5B
$15.4M 0.15%
57,128
+23,648
+71% +$6.08M
AMSC icon
193
American Superconductor
AMSC
$1.42B
$15.2M 0.15%
839,843
-102,855
-11% -$2.56M
SN icon
194
SharkNinja
SN
$22.9B
$15M 0.14%
179,483
-6,643
-4% -$676K
SMIN icon
195
iShares MSCI India Small-Cap ETF
SMIN
$756M
$14.8M 0.14%
+217,174
New +$14.8M
BLFY
196
DELISTED
Blue Foundry Bancorp
BLFY
$14.7M 0.14%
1,595,622
-112,154
-7% -$1.07M
ATMU icon
197
Atmus Filtration Technologies
ATMU
$4.22B
$14.6M 0.14%
397,909
-1,478
-0.4% -$58.3K
AYI icon
198
Acuity Brands
AYI
$9.83B
$14.3M 0.14%
54,365
+17,061
+46% +$5.16M
LB
199
LandBridge Co
LB
$2.16B
$14.1M 0.14%
195,500
-720
-0.4% -$50.9K
VITL icon
200
Vital Farms
VITL
$545M
$14M 0.14%
460,693
+91,580
+25% +$3.29M

Similar funds

Driehaus Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Driehaus Capital Management held 476 positions worth $10.4B, down 14% from $12.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Driehaus Capital Management withdrew a net $623M in Q1 2025, closing 82 positions and reducing 143 holdings. Its most notable exit was Core Scientific, an estimated $144M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, Driehaus Capital Management opened a new position in Guardant Health worth $82.3M.

  • Driehaus Capital Management's largest Q1 2025 buy was Guardant Health: 1,933,086 shares worth $82.3M.
  • Driehaus Capital Management added most to Elastic in Q1 2025, an estimated $85.5M increase.
  • Driehaus Capital Management's biggest Q1 2025 reduction was Modine Manufacturing, cutting an estimated $118M.
  • Driehaus Capital Management fully exited Core Scientific in Q1 2025, selling an estimated $144M.
  • Driehaus Capital Management's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2025.
  • Driehaus Capital Management opened 95 new positions and closed 82 in Q1 2025.
  • Driehaus Capital Management's portfolio value fell 14% quarter-over-quarter to $10.4B.

Based on Driehaus Capital Management's 13F filing for Q1 2025, filed 15 May 2025.